Acne Vulgaris - Pipeline Insight, 2018
SKU ID :DEL-11290776 | Published Date: 01-Jan-2018 | No. of pages: 90Description
TOC
1. Report Introduction
2. Acne Vulgaris Overview
3. Pipeline Therapeutics
• An Overview of Pipeline Products for Acne Vulgaris
4. Comparative Analysis
5. Products in Clinical Stage
5.1 Drug Name : Company Name
• Product Description
• Research and Development
• Product Development Activities
6. Products in Pre-Clinical and Discovery Stage
6.1 Drug Name : Company Name
• Product Description
• Research and Development
• Product Development Activities
7. Therapeutic Assessment
• Assessment by Route of Administration
• Assessment by Stage and Route of Administration
• Assessment by Molecule Type
• Assessment by Stage and Molecule Type
8. Inactive Products
8.1 Drug Name : Company Name
• Product Description
• Research and Development
• Product Development Activities
Appendix
Report Methodology
Consulting Services
Disclaimer
About DelveInsight
Tables & Figures
Table 1: Total Products for Acne Vulgaris
Table 2: Products in Clinical Stage
Table 3: Products in Non-clinical Stage
Table 4: Assessment by Route of Administration
Table 5: Assessment by Stage and Route of Administration
Table 6: Assessment by Molecule Type
Table 7: Assessment by Stage and Molecule Type
Table 8: Inactive Products
Figure 1: Total Products for Acne Vulgaris
Figure 2: Products in Clinical Stage
Figure 3: Products in Non-clinical Stage
Figure 4: Assessment by Route of Administration
Figure 5: Assessment by Stage and Route of Administration
Figure 6: Assessment by Molecule Type
Figure 7: Assessment by Stage and Molecule Type
Figure 8: Inactive Products
Companies
Allergan Pharma
Almirall
AndroScience Corporation
AntibioTx
AntiCancer
AOBiome
Arkin Dermatology
Basilea Pharmaceutica
Biomar Microbial Technologies
BioPharmX
Blueberry Therapeutics
Botanix Pharmaceuticals Ltd.
Braintree Laboratories
Brickell Biotech Inc.
Cassiopea SpA
& list continues...
- PRICE
-
$2000$6000